Both in Pharmaceuticals
Nektar Therapeutics vs Biohaven
Over the past year NKTR returned +0.5% and BHVN returned −9.3%; their daily moves had a correlation of 0.13.
NKTR +0.5% BHVN −9.3%Growth of $1, one year, split-adjusted
| Metric | NKTR | BHVN |
|---|---|---|
| Price | $59.24 | $13.29 |
| Market cap | $2.02B | $2.01B |
| Today | −1.92% | +0.15% |
| 1 month | −18.3% | −13.8% |
| 6 months | −9.2% | +64.3% |
| Year to date | +40.1% | +17.7% |
| 1 year | +1.3% | −11.4% |
| Revenue growth (YoY) | −9.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −401.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 37.1× | — |
| Net cash | $684.3M | $8.4M |
| Dividend yield | — | — |
| Volatility (60d) | 43.7% | 78.8% |
| Short % of float | 17.3% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).